Project Grant R01MH146153
- The National Institute of Mental Health awarded the University of Southern California $110,228 on November 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to investigate longitudinal effects of ADHD medication usage on neurodevelopment in adolescents. The project analyzes three waves of data (ages 9–10, 11–12, and 13–14 years) from the Adolescent Brain and Cognitive Development (ABCD) study cohort of 11,800 participants to identify cortical, subcortical, and white matter...
- The National Institute of Mental Health awarded Cincinnati Children's Hospital Medical Center $820,196 on March 5, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct observational and mechanistic research on circadian misalignment in adolescents with attention-deficit/hyperactivity disorder (ADHD). The project investigates how the timing mismatch between adolescents' internal circadian phase and early school start times affects attention and functional outcomes in...
- The National Institute of Mental Health awarded Florida International University $809,160 on September 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to develop and test novel approaches to supporting elementary school students with ADHD within multi-tiered systems of support (MTSS). The project, titled "Novel Approaches to Supporting Students with ADHD in Multi-Tiered Systems of Support," addresses behavioral difficulties in the classroom that inhibit...
- The National Institute of Mental Health awarded Minnesota Healthsolutions Corporation $353,306 on July 6, 2026, under the Mental Health Research Grants program (CFDA 93.242) to develop a digital health platform supporting parents of teenagers with ADHD who are learning to drive or recently licensed. The project will create an app enabling joint parent-teen goal setting, monitoring, and personalized feedback using telematics data. Development will incorporate evidence-based engagement...
- The National Institute of Mental Health awarded Children's Hospital Los Angeles $769,500 on March 15, 2026, under the Mental Health Research Grants program (CFDA 93.242) to evaluate the feasibility, acceptability, and preliminary effectiveness of Cognitive Behavioral Therapy for Depression in Autistic Youth (CBT-DAY) delivered by clinicians with limited autism training to verbally-fluent autistic youth with depression. The project develops and tests CBT-DAY, an autism-adapted intervention...
- The National Institute of Mental Health awarded Cincinnati Children's Hospital Medical Center $802,494 on May 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct a longitudinal study of cognitive disengagement syndrome as a transdiagnostic predictor of psychopathology across adolescence. The funded research extends an ongoing longitudinal study tracking 341 community-recruited adolescents (ages 10–12 years at baseline, enriched for cognitive disengagement syndrome...
- The National Institute of Mental Health awarded Children's Research Institute $479,144 on August 5, 2026, under the Mental Health Research Grants program (CFDA 93.242) to develop and test Unstuck and On Target for Early Childhood (Unstuck-EC), a tier 2 executive function intervention for preschool children with disabilities. The award funds a randomized controlled trial comparing Unstuck-EC, implemented by preschool classroom teachers, against services-as-usual care. Unstuck-EC adapts the...
- The National Institute of Mental Health awarded The University of Kentucky Research Foundation $2,695,895 on September 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct a longitudinal study examining the relationship between circulating estrogen levels and ADHD symptoms, cognitive performance, and affective outcomes in adolescent girls across the menstrual cycle. The study will recruit 100 adolescents under age 18 at later pubertal stages with regular menstrual...
- The National Institute of Mental Health awarded San Diego State University Foundation $395,457 on July 6, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct a hybrid effectiveness-implementation pilot of personalized Parent-Child Interaction Therapy (My PCIT) in community mental health settings. The study will gather preliminary data on the effectiveness and self-sustaining implementability of My PCIT, a personalized version of behavioral parent training designed to...
- The National Institute of Mental Health awarded Oregon Research Behavioral Intervention Strategies, Inc. (doing business as Influents Innovations) $314,362 under the Mental Health Research Grants program (CFDA 93.242) on September 1, 2026, to develop a digital evidence-based app for providers and teens addressing depression and subclinical depressive symptoms in youth. The project addresses the gap between the prevalence of depressive symptoms in adolescents and access to treatment. Cognitive...
The National Institute of Mental Health awarded Seattle Children's Research Institute $895,798 on August 5, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct a randomized hybrid implementation-effectiveness trial evaluating motivational interviewing enhanced cognitive behavior therapy for adults with ADHD. The trial will test combined CBT+MI against CBT alone, enrolling 216 adults with ADHD across 72 independent telepsychology providers licensed as psychologists with current PsyPACT credentials. Year 1 includes a pilot open trial with 6 therapists and 6 clients, incorporating weekly feedback and end-of-trial focus groups to refine remote implementation supports and digitized manuals prior to the randomized controlled trial phase in years 2–5. Effectiveness outcomes measured at baseline, post-treatment, and one-year follow-up will include self-report and informant-reported ADHD symptoms, impairment, and comorbid depression and anxiety. The study addresses a gap in evidence-based treatment for adult ADHD, as cognitive behavioral therapy faces engagement and implementation challenges in real-world settings, while motivational interviewing has validated effectiveness across over 500 randomized controlled trials and prior successful application to adolescent ADHD populations. The award runs through April 30, 2031, with performance in Seattle, Washington. This is a Project Grant assistance type.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $895.8k | 8/6/26 |